Impax gets US FDA nod for generic urecholine tabs (PharmaBiz)
Impax Laboratories, Inc, a technology based specialty pharmaceutical company, announced that the US Food and Drug Administration (FDA) has granted approval of the company's Abbreviated New Drug Applications (ANDA) for generic versions of urecholine tablets (Bethanechol Chloride tablets USP) 5 mg, 10 mg, 25 mg, and 50 mg.

Alexion Pharmaceuticals initiated with "outperform" (New Ratings)
NEW YORK, November 7 (newratings.com) - Analyst M Aberman of Credit Suisse initiates coverage of Alexion Pharmaceuticals Inc ( ALXN.NAS ) with an "outperform" rating. The target price is set to $49.